[STOCK WATCH] HanmiPharm rises 2.46%
[THE INVESTOR] As of Apr. 28 01:10 P.M., HanmiPharm increased 2.5%, compared with yesterday, to 307,000 won(US$270.37). It had increased 4.07% through the past month. Standard deviation, the variableness index, was 2.7% on the same period over one month.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of HanmiPharm was proper, while its volatility within 1 month was the highest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 1.5.
The return-on-risk is below the industrial mean, 4.0, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.